The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do side ...

Eli Lilly (LLY) stock is in focus as the company's oral weight loss candidate orforglipron succeeds in two Phase 3 trials for ...

Despite the skyrocketing popularity of weight-loss drugs such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), following an appropriate eating plan remains foundational to weight ...

A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called ...

Eli Lilly said its investigational oral GLP-1 weight-loss drug, orforglipron, met its primary endpoints in two recent phase 3 trials. The medicine company said Wednesday the drug met the primary and ...

Pfizer PFE-0.20%decrease; red down pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR 0.19%increase; green up pointing triangle in a deal that gets the ...

SHANGHAI, Sept 23 (Reuters) - Innovent Biologics' (1801.HK), opens new tab newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. You’ve got a lot of choices when it comes to weight loss workouts for men. Running, burpees, jump rope, the elliptical — it can get ...